Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 91.12 | 28.95 |
| PEG Ratio (TTM) | 0.39 | 5.02 |
| P/S Ratio (TTM) | 5.04 | 89.85 |
| P/B Ratio (TTM) | 3.11 | 74.05 |
| P/FCF Ratio (TTM) | 15.81 | 65.18 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.86 |
| Price to 5YR AVG FCF Ratio | N/A | 50.98 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.24% | 4.62% |
| ROE (TTM) | 3.59% | 8.81% |
| Net Profit Margin (TTM) | 0.70% | -10.17% |
| ROIC 5YR AVG | N/A | 17.25% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -389.85% | 365.28% | N/A |
| Revenue | -0.84% | 20.14% | N/A |
| Net Income | -425.69% | 49.82% | N/A |
| Cash Flow | -2.08% | 18.25% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.20 | 5.91 |
| Quick Ratio (TTM) | 5.20 | 5.77 |
| D/E Ratio (TTM) | 5.04 | 0.70 |
| Interest Coverage (TTM) | 0.74 | 18.00 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 2.62 | 6.37 |
| LTL to 5YR AVG FCF | N/A | 2.48 |
| Shares Outstanding Growth 5YR AVG | N/A | 13.17% |